HIV cure-related studies in Australia
Here you will find details of current laboratory, social and clinical studies relating to HIV cure that are underway in Australia. Click on the ‘details’ link for more information about eligibility and what study participation would involve.
PAUSE THE PILLS: Would you interrupt treatment for HIV cure research?
There is no cure for HIV. Researchers worldwide are working on different ways to get rid of the virus. If you are living with HIV, we want to know how you feel about being involved in this type of research. We are conducting a short survey on what issues would affect your decision to take part.
If you are over 18 years old and living with HIV, you can do this survey. The survey is open to people from all countries and all backgrounds. This includes women, heterosexual men, gay and bisexual men and trans* people with HIV. You can participate regardless of how long you’ve had HIV or what treatment you are taking (if any).
The survey will take 10-15 minutes to complete.
For more information about the study, including contact details and to find out how to access the findings from this survey, click here.
PRADA: HIV Persistence in Reservoirs at Alfred, Doherty and The Avenue
This study involves looking for immune checkpoint markers on white blood cells from HIV+ participants. The aim is to see how these markers relate to the HIV reservoir.
Click here for a background article on this study and the investigation of immune checkpoint markers.
Principal investigator: Prof. Sharon Lewin, Doherty Institute
Recruitment location: Melbourne, Australia
Contact: Alfred Clinical Research Unit on 03 9076 6908
Leukapheresis: Large volume PBMC collection using leukapheresis to define HIV persistence in HIV infected adults
This study involves a detailed investigation of white blood cells from HIV+ participants, aiming to find which cell subsets contain virus and whether the virus found is infectious.
Click here to see an interview with Geoff, one of the leukapheresis trial participants.
Principal investigator: Prof. Sharon Lewin, Doherty Institute
Recruitment location: Melbourne, Australia
Contact: Alfred Clinical Research Unit on 03 9076 6908
HSCT: Impact of haematopoietic stem cell transplantation on HIV viral reservoirs in patients on combination antiretroviral therapy
This study investigates the effect of HSCT (for haematological issues) on the amount of HIV RNA and DNA in the CD4+ T cells of HIV+ participants.
Principal investigator: Prof. Sharon Lewin, Doherty Institute
Recruitment location: Melbourne, Australia
Contact: Alfred Clinical Research Unit on 03 9076 6908
